![Bryan Irving](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Irving
Corporate Officer/Principal chez
3T Biosciences, Inc.
Profil
Bryan A Irving is currently the Chief Scientific Officer at 3T Biosciences, Inc. He previously worked as a Senior Advisor at Frazier Management LLC, Chief Scientific Officer & Executive VP at Five Prime Therapeutics, Inc., Vice President & Cancer Immunology at CytomX Therapeutics Holdings LLC, and Chief Scientific Officer at Amunix Pharmaceuticals, Inc. Dr. Irving received his undergraduate degree from the University of California, Berkeley and his doctorate from The University of California, San Francisco.
Postes actifs de Bryan Irving
| Sociétés | Poste | Début |
|---|---|---|
3T Biosciences, Inc.
 3T Biosciences, Inc. BiotechnologyHealth Technology Operates as an immunotherapy company that develops next-generation and transformative therapies for the treatment of solid tumors and immune-mediated diseases | Corporate Officer/Principal | 01/10/2023 |
Anciens postes connus de Bryan Irving
| Sociétés | Poste | Fin |
|---|---|---|
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Corporate Officer/Principal | 01/07/2022 |
| FIVE PRIME THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 30/05/2019 |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology Engaged in the development of new generation targeted antibody therapeutics | Private Equity Investor | 01/08/2017 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Consultant / Advisor | - |
Formation de Bryan Irving
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics Holdings LLC
CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology Engaged in the development of new generation targeted antibody therapeutics | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Health Technology |
3T Biosciences, Inc.
3T Biosciences, Inc. BiotechnologyHealth Technology Operates as an immunotherapy company that develops next-generation and transformative therapies for the treatment of solid tumors and immune-mediated diseases | Health Technology |
Choisissez Zonebourse 
